INOVIO PHARMACEUTICALS, INC. Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price
INOVIO PHARMACEUTICALS, INC. (INO) had Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price of $42.81 per share as of 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 · last filed 2026-03-12
- 2025-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price $42.81.
- 2024-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price $59.52.
- 2023-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price $72.11.
- 2022-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price $6.79.
| Period end | Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price |
|---|---|
| 2025-12-31 | $42.81 10-K · filed 2026-03-12 |
| 2024-12-31 | $59.52 10-K · filed 2025-03-18 |
| 2023-12-31 | $72.11 10-K · filed 2024-03-06 |
| 2022-12-31 | $6.79 10-K · filed 2023-03-01 |
| 2021-12-31 | $7.22 10-K · filed 2022-03-01 |
| 2020-12-31 | $6.58 10-K · filed 2021-03-01 |
| 2019-12-31 | $6.37 10-K · filed 2020-03-12 |
| 2018-12-31 | $6.78 10-K · filed 2019-03-12 |
| 2017-12-31 | $6.68 10-K · filed 2018-03-14 |
| 2016-12-31 | $6.26 10-K · filed 2017-03-15 |
| 2015-12-31 | $5.70 10-K · filed 2016-03-14 |
| 2014-12-31 | $5.48 10-K · filed 2015-03-16 |
| 2013-12-31 | $1.38 10-K · filed 2014-03-17 |
| 2012-12-31 | $1.39 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |